| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Salter Malcolm is a Director at C4 Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $47K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $30.25 | $22,838.75 | -6.4% | -23.7% | -76.6% | |
| Nov 19, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $40.11 | $30,283.05 | -6.1% | -42.2% | -74.8% | |
| Oct 15, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $44.94 | $33,929.70 | -5.7% | -38.4% | -81.9% | |
| Sep 17, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $49.89 | $37,666.95 | -5.5% | -38.9% | -80.3% | |
| Aug 20, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $40.73 | $30,751.15 | -5.2% | -1.5% | -72.4% | |
| Jul 16, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $37.37 | $28,214.35 | -5.0% | +10.7% | -74.9% | |
| Jun 18, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $37.19 | $28,078.45 | -4.8% | +30.6% | -85.8% | |
| May 21, 2021 | CCCC C4 Therapeutics, Inc. | Director | Sell | 755 | $37.12 | $28,025.60 | -4.6% | +12.2% | -81.7% | |
| Oct 6, 2020 | CCCC C4 Therapeutics, Inc. | Director | Buy | 1,315 | $19.00 | $24,985.00 | +9.0% | - | - |